1 / 8

R&I: Cryptococcal Meningitis Global Clinical Trials Review

GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Cryptococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptococcal Meningitis. Detailed report at: http://www.reportsandintelligence.com/cryptococcal-meningitis-global-clinical-trials-review-h2-2014-market

BellaWilson111
Download Presentation

R&I: Cryptococcal Meningitis Global Clinical Trials Review

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014 Publisher: Global Data No of pages: 76 Publish Date: Nov2014

  2. Description GlobalData's clinical trial report, “Cryptococcal Meningitis Global Clinical Trials Review, H2, 2014" provides data on the Cryptococcal Meningitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptococcal Meningitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cryptococcal Meningitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Enquire about report at: http://www.reportsandintelligence.com/enquire-about-report/153550

  3. Scope • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type • Listings of discontinued trials (suspended, withdrawn and terminated) • Get all reports of Pharmaceutical category at: http://www.reportsandintelligence.com/pharmaceuticals-market-report

  4. Reasons to buy • Understand the dynamics of a particular indication in a condensed manner • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more • Obtain discontinued trial listing for trials across the globe • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies • View detailed report at: http://www.reportsandintelligence.com/cryptococcal-meningitis-global-clinical-trials-review-h2-2014-market

  5. Table Of Content Table of Contents 2List of Tables 4List of Figures 5Introduction 6Cryptococcal Meningitis 6Report Guidance 6Clinical Trials by Region 7Clinical Trials and Average Enrollment by Country 8Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10Top Countries Contributing to Clinical Trials in Europe 11Top Countries Contributing to Clinical Trials in North America 12Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13Top Countries Contributing to Clinical Trials in Central and South America 14Clinical Trials by G7 Countries: Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16

  6. Table Of Content Clinical Trials in G7 Countries by Trial Status 17Clinical Trials by E7 Countries: Proportion of Cryptococcal Meningitis to Infectious Disease Clinical Trials 18Clinical Trials in E7 Countries by Trial Status 19Clinical Trials by Phase 20In Progress Trials by Phase 21Clinical Trials by Trial Status 22Clinical Trials by End Point Status 23Unaccomplished Trials of Cryptococcal Meningitis 24Subjects Recruited Over a Period of Time 25Clinical Trials by Sponsor Type 26Prominent Sponsors 27Top Companies Participating in Cryptococcal Meningitis Therapeutics Clinical Trials 28 Prominent Drugs 29Clinical Trial Profiles 30 Clinical Trial Overview of Top Companies 30

  7. Table Of Content Pfizer Inc. 30Clinical Trial Overview of Pfizer Inc. 30TTY Biopharm Company Limited 31Clinical Trial Overview of TTY Biopharm Company Limited 31Novartis AG 32Clinical Trial Overview of Novartis AG 32Liposome Company, Inc 33Clinical Trial Overview of Liposome Company, Inc 33AlkermesPlc 34Clinical Trial Overview of AlkermesPlc 34Clinical Trial Overview of Top Institutes / Government 35 The National Institute of Allergy and Infectious Diseases 35 Get full TOC at: http://www.reportsandintelligence.com/cryptococcal-meningitis-global-clinical-trials-review-h2-2014-market/table-of-contents

  8. FOR MORE DETAILS Visit us at : http://www.reportsandintelligence.com/cryptococcal-meningitis-global-clinical-trials-review-h2-2014-market Stay With Us: • TELEPHONE: Direct: +1 (617) 674-4143 • Toll Free: +1 (855) 711-1555E-MAIL: sales@reportsandintelligence.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States

More Related